Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 23.41 Million CNY | 6.23% |
| 2022 | 24.97 Million CNY | -45.61% |
| 2021 | 45.92 Million CNY | -42.73% |
| 2020 | 80.17 Million CNY | -45.63% |
| 2019 | 147.46 Million CNY | 7.82% |
| 2018 | 136.77 Million CNY | 92.15% |
| 2017 | 71.18 Million CNY | 49.37% |
| 2016 | 47.65 Million CNY | 60.05% |
| 2015 | 29.77 Million CNY | -50.2% |
| 2014 | 59.78 Million CNY | -28.14% |
| 2013 | 83.2 Million CNY | 36.11% |
| 2012 | 61.12 Million CNY | -44.36% |
| 2011 | 109.85 Million CNY | 4.72% |
| 2010 | 104.91 Million CNY | 9.86% |
| 2009 | 95.49 Million CNY | -19.9% |
| 2008 | 119.22 Million CNY | 47.07% |
| 2007 | 81.06 Million CNY | 1.38% |
| 2006 | 79.96 Million CNY | -8.98% |
| 2005 | 87.85 Million CNY | 8.62% |
| 2004 | 80.88 Million CNY | 6.71% |
| 2003 | 75.79 Million CNY | 7.93% |
| 2002 | 70.22 Million CNY | 2.49% |
| 2001 | 68.52 Million CNY | 23.95% |
| 2000 | 55.28 Million CNY | -6.25% |
| 1999 | 58.96 Million CNY | 41.93% |
| 1998 | 41.54 Million CNY | 50.28% |
| 1997 | 27.64 Million CNY | 32.26% |
| 1996 | 20.9 Million CNY | 32.35% |
| 1995 | 15.79 Million CNY | -72.21% |
| 1994 | 56.82 Million CNY | 214.39% |
| 1993 | 18.07 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 8.43 Million CNY | 22.05% |
| 2024 Q3 | 36.65 Million CNY | 379.0% |
| 2024 Q2 | 7.65 Million CNY | -9.29% |
| 2023 Q2 | 6.93 Million CNY | 51.51% |
| 2023 Q1 | 4.57 Million CNY | -41.84% |
| 2023 FY | 26.53 Million CNY | 6.23% |
| 2023 Q3 | 8.11 Million CNY | 16.98% |
| 2023 Q4 | 6.91 Million CNY | -14.78% |
| 2022 Q3 | 6.64 Million CNY | 54.4% |
| 2022 Q1 | 6.15 Million CNY | -55.55% |
| 2022 FY | 24.97 Million CNY | -45.61% |
| 2022 Q4 | 7.86 Million CNY | 18.39% |
| 2022 Q2 | 4.3 Million CNY | -30.11% |
| 2021 FY | 45.92 Million CNY | -42.73% |
| 2021 Q1 | 10.34 Million CNY | -38.1% |
| 2021 Q2 | 10.69 Million CNY | 3.39% |
| 2021 Q3 | 11.03 Million CNY | 3.2% |
| 2021 Q4 | 13.85 Million CNY | 25.56% |
| 2020 FY | 80.17 Million CNY | -45.63% |
| 2020 Q1 | 20.98 Million CNY | -41.49% |
| 2020 Q2 | 21.39 Million CNY | 1.96% |
| 2020 Q3 | 21.1 Million CNY | -1.36% |
| 2020 Q4 | 16.7 Million CNY | -20.84% |
| 2019 Q3 | 38.13 Million CNY | -8.01% |
| 2019 Q1 | 32.02 Million CNY | 25.94% |
| 2019 Q2 | 41.45 Million CNY | 29.45% |
| 2019 Q4 | 35.85 Million CNY | -5.97% |
| 2019 FY | 147.46 Million CNY | 7.82% |
| 2018 Q1 | 29.84 Million CNY | -20.28% |
| 2018 Q2 | 51.57 Million CNY | 72.79% |
| 2018 Q3 | 29.91 Million CNY | -42.0% |
| 2018 Q4 | 25.42 Million CNY | -15.01% |
| 2018 FY | 136.77 Million CNY | 92.15% |
| 2017 Q4 | 37.44 Million CNY | 155.06% |
| 2017 Q2 | 9.39 Million CNY | -2.84% |
| 2017 Q1 | 9.66 Million CNY | -51.99% |
| 2017 FY | 71.18 Million CNY | 49.37% |
| 2017 Q3 | 14.68 Million CNY | 56.33% |
| 2016 FY | 47.65 Million CNY | 60.05% |
| 2016 Q3 | 12.62 Million CNY | 97.58% |
| 2016 Q2 | 6.38 Million CNY | -24.89% |
| 2016 Q1 | 8.5 Million CNY | -13.6% |
| 2016 Q4 | 20.13 Million CNY | 59.5% |
| 2015 Q1 | 6.57 Million CNY | -60.13% |
| 2015 FY | 29.77 Million CNY | -50.2% |
| 2015 Q4 | 9.84 Million CNY | 36.41% |
| 2015 Q3 | 7.21 Million CNY | 17.62% |
| 2015 Q2 | 6.13 Million CNY | -6.68% |
| 2014 Q4 | 16.49 Million CNY | -4.82% |
| 2014 FY | 59.78 Million CNY | -28.14% |
| 2014 Q1 | 13.36 Million CNY | -55.86% |
| 2014 Q2 | 12.6 Million CNY | -5.7% |
| 2014 Q3 | 17.32 Million CNY | 37.49% |
| 2013 FY | 83.2 Million CNY | 36.11% |
| 2013 Q2 | 15.85 Million CNY | -13.65% |
| 2013 Q4 | 30.27 Million CNY | 61.85% |
| 2013 Q3 | 18.7 Million CNY | 17.97% |
| 2013 Q1 | 18.36 Million CNY | 44.84% |
| 2012 FY | 61.12 Million CNY | -44.36% |
| 2012 Q4 | 12.67 Million CNY | -26.2% |
| 2012 Q2 | 19.19 Million CNY | 58.93% |
| 2012 Q3 | 17.17 Million CNY | -10.5% |
| 2012 Q1 | 12.07 Million CNY | -55.78% |
| 2011 Q4 | 27.31 Million CNY | 12.34% |
| 2011 Q1 | 32.79 Million CNY | 10.33% |
| 2011 Q3 | 24.31 Million CNY | -4.42% |
| 2011 Q2 | 25.43 Million CNY | -22.43% |
| 2011 FY | 109.85 Million CNY | 4.72% |
| 2010 Q1 | 24.62 Million CNY | 13.68% |
| 2010 Q2 | 26.44 Million CNY | 7.41% |
| 2010 Q3 | 24.12 Million CNY | -8.79% |
| 2010 Q4 | 29.72 Million CNY | 23.22% |
| 2010 FY | 104.91 Million CNY | 9.86% |
| 2009 Q2 | 26.88 Million CNY | 5.59% |
| 2009 Q3 | 21.49 Million CNY | -20.03% |
| 2009 Q1 | 25.45 Million CNY | -20.26% |
| 2009 FY | 95.49 Million CNY | -19.9% |
| 2009 Q4 | 21.65 Million CNY | 0.74% |
| 2008 Q1 | 36.16 Million CNY | 79.26% |
| 2008 Q4 | 31.92 Million CNY | 49.17% |
| 2008 Q3 | 21.4 Million CNY | -28.01% |
| 2008 FY | 119.22 Million CNY | 47.07% |
| 2008 Q2 | 29.72 Million CNY | -17.81% |
| 2007 Q2 | 22.6 Million CNY | -2.9% |
| 2007 Q4 | 20.17 Million CNY | 34.42% |
| 2007 Q3 | 15.01 Million CNY | -33.6% |
| 2007 Q1 | 23.27 Million CNY | 38.29% |
| 2007 FY | 81.06 Million CNY | 1.38% |
| 2006 Q1 | 22.54 Million CNY | -1.91% |
| 2006 FY | 79.96 Million CNY | -8.98% |
| 2006 Q4 | 16.83 Million CNY | -15.77% |
| 2006 Q3 | 19.98 Million CNY | -3.03% |
| 2006 Q2 | 20.6 Million CNY | -8.57% |
| 2005 Q3 | 19.49 Million CNY | -14.6% |
| 2005 Q1 | 22.54 Million CNY | 1.76% |
| 2005 FY | 87.85 Million CNY | 8.62% |
| 2005 Q2 | 22.83 Million CNY | 1.27% |
| 2005 Q4 | 22.98 Million CNY | 17.85% |
| 2004 FY | 80.88 Million CNY | 6.71% |
| 2004 Q4 | 22.15 Million CNY | 19.16% |
| 2004 Q1 | 19.76 Million CNY | -4.03% |
| 2004 Q2 | 20.37 Million CNY | 3.08% |
| 2004 Q3 | 18.59 Million CNY | -8.73% |
| 2003 Q2 | 19.79 Million CNY | 3.21% |
| 2003 FY | 75.79 Million CNY | 7.93% |
| 2003 Q4 | 20.59 Million CNY | 26.97% |
| 2003 Q1 | 19.18 Million CNY | 3.84% |
| 2003 Q3 | 16.21 Million CNY | -18.08% |
| 2002 Q3 | 15.55 Million CNY | -11.23% |
| 2002 Q4 | 18.47 Million CNY | 18.73% |
| 2002 Q1 | 18.66 Million CNY | -3.68% |
| 2002 FY | 70.22 Million CNY | 2.49% |
| 2002 Q2 | 17.52 Million CNY | -6.08% |
| 2001 FY | 68.52 Million CNY | 23.95% |
| 2001 Q4 | 19.37 Million CNY | 24.55% |
| 2001 Q3 | 15.55 Million CNY | 0.0% |
| 2000 FY | 55.28 Million CNY | -6.25% |
| 1999 FY | 58.96 Million CNY | 41.93% |
| 1998 FY | 41.54 Million CNY | 50.28% |
| 1997 FY | 27.64 Million CNY | 32.26% |
| 1996 FY | 20.9 Million CNY | 32.35% |
| 1995 FY | 15.79 Million CNY | -72.21% |
| 1994 FY | 56.82 Million CNY | 214.39% |
| 1993 FY | 18.07 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 19.29 Billion CNY | 99.879% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 4.59 Billion CNY | 99.491% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.89 Billion CNY | 99.399% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.13 Billion CNY | 97.944% |
| Aurora Optoelectronics Co.,Ltd. | -319.56 Million CNY | 107.326% |
| NanJing Pharmaceutical Company Limited | 3.31 Billion CNY | 99.293% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 936.59 Million CNY | 97.5% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 99.046% |